SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000827871-15-000023
Filing Date
2015-04-13
Accepted
2015-04-13 08:05:49
Documents
3
Period of Report
2015-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k.htm 8-K 24329
2 EXHIBIT 99.1 eaglerelease041315.htm EX-99.1 7968
3 eaglelogo.jpg GRAPHIC 85201
  Complete submission text file 0000827871-15-000023.txt   151131
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 15765785
SIC: 2834 Pharmaceutical Preparations